Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07360860
Eligibility Criteria:
Inclusion Criteria: • Both genders were included.
* Patients above 18 years old.
* Patients diagnosed by macular amyloidosis, proved by dermoscopy and histopathology.
Exclusion Criteria: • Prior use of topical therapies in the previous 4 weeks.
* Prior use of any procedures such as chemical peel or laser treatment in the previous 1 month.
* Prior use of any systemic treatment for macular amyloidosis in the past 12 weeks.
* Patients with other skin conditions (e.g., psoriasis, eczema).
* Immunocompromised patients (HIV, chemotherapy).
* Patients with history of any type of autoimmune disorders, coagulopathies, and keloid tendency.
* Known or suspected allergy to ingredients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07360860
Study Brief:
Protocol Section:
NCT07360860